These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 18661544)

  • 1. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2009 Mar; 98(3):812-43. PubMed ID: 18661544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate delivery systems for animal vaccines.
    Scheerlinck JP; Greenwood DL
    Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles and microparticles as vaccine-delivery systems.
    Singh M; Chakrapani A; O'Hagan D
    Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
    Alshweiat A; Ambrus R; Csoka I
    Curr Med Chem; 2019; 26(35):6459-6492. PubMed ID: 31453778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as delivery systems for nasal vaccination: strategies and outcomes.
    Heurtault B; Frisch B; Pons F
    Expert Opin Drug Deliv; 2010 Jul; 7(7):829-44. PubMed ID: 20459361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles as carriers for nasal vaccine delivery.
    Köping-Höggård M; Sánchez A; Alonso MJ
    Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan.
    Popescu R; Ghica MV; Dinu-Pîrvu CE; Anuța V; Lupuliasa D; Popa L
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal vaccine innovation.
    Jabbal-Gill I
    J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
    Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
    Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
    Badiee A; Heravi Shargh V; Khamesipour A; Jaafari MR
    Vaccine; 2013 Jan; 31(5):735-49. PubMed ID: 23219436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Chaud MV; Evangelista RC; Gremião MP
    Curr Drug Deliv; 2006 Jul; 3(3):275-85. PubMed ID: 16848729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal delivery of vaccines.
    Almeida AJ; Alpar HO
    J Drug Target; 1996; 3(6):455-67. PubMed ID: 8863138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.
    Zaman M; Simerska P; Toth I
    Curr Drug Deliv; 2010 Apr; 7(2):118-24. PubMed ID: 20158484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloidal drug delivery systems in vaccine delivery.
    Beg S; Samad A; Nazish I; Sultana R; Rahman M; Ahmad MZ; Akbar M
    Curr Drug Targets; 2013 Jan; 14(1):123-37. PubMed ID: 23072326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.